|
Volumn 347, Issue 26, 2002, Pages 2165-2168
|
Minimally invasive bypass surgery [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
FIBRINOGEN RECEPTOR ANTAGONIST;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
ANGIOPLASTY;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS SURGERY;
CORONARY ARTERY OBSTRUCTION;
CORONARY STENT;
EVIDENCE BASED MEDICINE;
HUMAN;
LEFT ANTERIOR DESCENDING CORONARY ARTERY;
LETTER;
MINIMALLY INVASIVE SURGERY;
PRIORITY JOURNAL;
RESTENOSIS;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
DRUG ANTAGONISM;
NOTE;
STENT;
TRANSLUMINAL CORONARY ANGIOPLASTY;
DISEASE FREE SURVIVAL;
PATHOLOGY;
RISK FACTOR;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
TIME;
METHODOLOGY;
POSTOPERATIVE COMPLICATION;
ROBOTICS;
CARDIOPULMONARY BYPASS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY ARTERY BYPASS;
CORONARY DISEASE;
CORONARY RESTENOSIS;
DISEASE-FREE SURVIVAL;
HUMAN;
RISK FACTORS;
STENTS;
SURGICAL PROCEDURES, MINIMALLY INVASIVE;
ANTIBODIES, MONOCLONAL;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
POSTOPERATIVE COMPLICATIONS;
ROBOTICS;
CARDIOPULMONARY BYPASS;
|
EID: 0037180784
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200212263472613 Document Type: Letter |
Times cited : (2)
|
References (0)
|